nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2B6—Thiotepa—urinary bladder cancer	0.105	0.218	CbGbCtD
Nicardipine—ABCB1—Mitomycin—urinary bladder cancer	0.0713	0.147	CbGbCtD
Nicardipine—CYP3A4—Thiotepa—urinary bladder cancer	0.0324	0.0669	CbGbCtD
Nicardipine—CYP2B6—Cisplatin—urinary bladder cancer	0.0291	0.0601	CbGbCtD
Nicardipine—CYP2E1—Etoposide—urinary bladder cancer	0.029	0.0598	CbGbCtD
Nicardipine—ADRA1B—vas deferens—urinary bladder cancer	0.0262	0.163	CbGeAlD
Nicardipine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0259	0.0536	CbGbCtD
Nicardipine—CYP3A5—Etoposide—urinary bladder cancer	0.0225	0.0465	CbGbCtD
Nicardipine—CYP2C8—Etoposide—urinary bladder cancer	0.0216	0.0447	CbGbCtD
Nicardipine—ABCB1—Gemcitabine—urinary bladder cancer	0.0205	0.0424	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—urinary bladder cancer	0.0195	0.0403	CbGbCtD
Nicardipine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0181	0.0374	CbGbCtD
Nicardipine—CYP2C9—Cisplatin—urinary bladder cancer	0.0154	0.0317	CbGbCtD
Nicardipine—ABCB1—Cisplatin—urinary bladder cancer	0.0149	0.0308	CbGbCtD
Nicardipine—ABCB1—Etoposide—urinary bladder cancer	0.0147	0.0303	CbGbCtD
Nicardipine—CHRM3—ureter—urinary bladder cancer	0.0123	0.0763	CbGeAlD
Nicardipine—ABCB1—Doxorubicin—urinary bladder cancer	0.01	0.0206	CbGbCtD
Nicardipine—ABCB1—Methotrexate—urinary bladder cancer	0.00968	0.02	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00942	0.0195	CbGbCtD
Nicardipine—CHRM3—muscle of abdomen—urinary bladder cancer	0.00885	0.0549	CbGeAlD
Nicardipine—CYP3A4—Etoposide—urinary bladder cancer	0.00878	0.0181	CbGbCtD
Nicardipine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00599	0.0124	CbGbCtD
Nicardipine—PDE1B—prostate gland—urinary bladder cancer	0.00428	0.0266	CbGeAlD
Nicardipine—CYP2C19—urine—urinary bladder cancer	0.00371	0.023	CbGeAlD
Nicardipine—PDE1A—prostate gland—urinary bladder cancer	0.00359	0.0223	CbGeAlD
Nicardipine—CYP2C9—urine—urinary bladder cancer	0.00288	0.0179	CbGeAlD
Nicardipine—CYP2E1—urine—urinary bladder cancer	0.00273	0.0169	CbGeAlD
Nicardipine—CACNB2—prostate gland—urinary bladder cancer	0.00264	0.0164	CbGeAlD
Nicardipine—PDE1A—smooth muscle tissue—urinary bladder cancer	0.00254	0.0158	CbGeAlD
Nicardipine—CACNA2D1—prostate gland—urinary bladder cancer	0.00248	0.0154	CbGeAlD
Nicardipine—PDE1A—renal system—urinary bladder cancer	0.00244	0.0152	CbGeAlD
Nicardipine—PDE1B—female reproductive system—urinary bladder cancer	0.00234	0.0145	CbGeAlD
Nicardipine—CACNA1D—prostate gland—urinary bladder cancer	0.00231	0.0143	CbGeAlD
Nicardipine—ADRA1D—prostate gland—urinary bladder cancer	0.00229	0.0142	CbGeAlD
Nicardipine—CYP3A4—urine—urinary bladder cancer	0.00219	0.0136	CbGeAlD
Nicardipine—CYP2D6—urine—urinary bladder cancer	0.00216	0.0134	CbGeAlD
Nicardipine—CACNA1C—prostate gland—urinary bladder cancer	0.00213	0.0132	CbGeAlD
Nicardipine—PDE1A—female reproductive system—urinary bladder cancer	0.00196	0.0122	CbGeAlD
Nicardipine—CHRM5—epithelium—urinary bladder cancer	0.00188	0.0117	CbGeAlD
Nicardipine—CALM3—prostate gland—urinary bladder cancer	0.00179	0.0111	CbGeAlD
Nicardipine—CHRM2—prostate gland—urinary bladder cancer	0.00176	0.0109	CbGeAlD
Nicardipine—ADRA1D—epithelium—urinary bladder cancer	0.00168	0.0105	CbGeAlD
Nicardipine—CHRM1—prostate gland—urinary bladder cancer	0.0016	0.00995	CbGeAlD
Nicardipine—ADRA1B—renal system—urinary bladder cancer	0.0016	0.00991	CbGeAlD
Nicardipine—ADRA1D—urethra—urinary bladder cancer	0.00153	0.00953	CbGeAlD
Nicardipine—CALM3—seminal vesicle—urinary bladder cancer	0.00151	0.00938	CbGeAlD
Nicardipine—CACNA1C—smooth muscle tissue—urinary bladder cancer	0.00151	0.00938	CbGeAlD
Nicardipine—CHRM3—prostate gland—urinary bladder cancer	0.00143	0.0089	CbGeAlD
Nicardipine—CALM2—prostate gland—urinary bladder cancer	0.0014	0.00871	CbGeAlD
Nicardipine—CALM1—prostate gland—urinary bladder cancer	0.0014	0.00867	CbGeAlD
Nicardipine—PDE1B—lymph node—urinary bladder cancer	0.00137	0.00848	CbGeAlD
Nicardipine—ADRA1A—prostate gland—urinary bladder cancer	0.00132	0.00817	CbGeAlD
Nicardipine—CACNB2—vagina—urinary bladder cancer	0.0013	0.0081	CbGeAlD
Nicardipine—CALM3—smooth muscle tissue—urinary bladder cancer	0.00126	0.00785	CbGeAlD
Nicardipine—ADRA1D—female reproductive system—urinary bladder cancer	0.00125	0.00777	CbGeAlD
Nicardipine—CACNA2D1—vagina—urinary bladder cancer	0.00123	0.00761	CbGeAlD
Nicardipine—CALM3—urethra—urinary bladder cancer	0.0012	0.00743	CbGeAlD
Nicardipine—CALM2—seminal vesicle—urinary bladder cancer	0.00119	0.00737	CbGeAlD
Nicardipine—CACNA1C—female reproductive system—urinary bladder cancer	0.00116	0.00723	CbGeAlD
Nicardipine—PDE1A—lymph node—urinary bladder cancer	0.00114	0.00711	CbGeAlD
Nicardipine—CACNA1C—vagina—urinary bladder cancer	0.00105	0.00654	CbGeAlD
Nicardipine—CYP3A5—prostate gland—urinary bladder cancer	0.00105	0.00652	CbGeAlD
Nicardipine—CALM2—epithelium—urinary bladder cancer	0.00103	0.0064	CbGeAlD
Nicardipine—CALM1—epithelium—urinary bladder cancer	0.00103	0.00637	CbGeAlD
Nicardipine—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00101	0.0063	CbGeAlD
Nicardipine—CALM2—smooth muscle tissue—urinary bladder cancer	0.000993	0.00617	CbGeAlD
Nicardipine—CALM1—smooth muscle tissue—urinary bladder cancer	0.000989	0.00614	CbGeAlD
Nicardipine—CYP2E1—prostate gland—urinary bladder cancer	0.000979	0.00608	CbGeAlD
Nicardipine—CHRM3—renal system—urinary bladder cancer	0.000977	0.00607	CbGeAlD
Nicardipine—ADRA1A—epithelium—urinary bladder cancer	0.000967	0.006	CbGeAlD
Nicardipine—CHRM3—urethra—urinary bladder cancer	0.000959	0.00596	CbGeAlD
Nicardipine—CALM2—renal system—urinary bladder cancer	0.000956	0.00594	CbGeAlD
Nicardipine—CALM1—renal system—urinary bladder cancer	0.000952	0.00591	CbGeAlD
Nicardipine—CALM2—urethra—urinary bladder cancer	0.000939	0.00583	CbGeAlD
Nicardipine—CALM1—urethra—urinary bladder cancer	0.000935	0.00581	CbGeAlD
Nicardipine—ADRA1A—renal system—urinary bladder cancer	0.000897	0.00557	CbGeAlD
Nicardipine—CALM3—vagina—urinary bladder cancer	0.000882	0.00548	CbGeAlD
Nicardipine—CHRM1—female reproductive system—urinary bladder cancer	0.000874	0.00543	CbGeAlD
Nicardipine—CACNB2—lymph node—urinary bladder cancer	0.000844	0.00524	CbGeAlD
Nicardipine—CYP2E1—seminal vesicle—urinary bladder cancer	0.000828	0.00514	CbGeAlD
Nicardipine—CACNA2D1—lymph node—urinary bladder cancer	0.000793	0.00492	CbGeAlD
Nicardipine—CYP2C8—renal system—urinary bladder cancer	0.000792	0.00492	CbGeAlD
Nicardipine—CHRM3—female reproductive system—urinary bladder cancer	0.000782	0.00486	CbGeAlD
Nicardipine—CALM2—female reproductive system—urinary bladder cancer	0.000766	0.00476	CbGeAlD
Nicardipine—CALM1—female reproductive system—urinary bladder cancer	0.000762	0.00473	CbGeAlD
Nicardipine—CACNA1D—lymph node—urinary bladder cancer	0.000738	0.00458	CbGeAlD
Nicardipine—CYP3A5—renal system—urinary bladder cancer	0.000715	0.00444	CbGeAlD
Nicardipine—CYP2B6—renal system—urinary bladder cancer	0.000711	0.00441	CbGeAlD
Nicardipine—CALM2—vagina—urinary bladder cancer	0.000693	0.0043	CbGeAlD
Nicardipine—CALM1—vagina—urinary bladder cancer	0.000689	0.00428	CbGeAlD
Nicardipine—CACNA1C—lymph node—urinary bladder cancer	0.000681	0.00423	CbGeAlD
Nicardipine—CYP2E1—renal system—urinary bladder cancer	0.000667	0.00414	CbGeAlD
Nicardipine—CYP2C19—vagina—urinary bladder cancer	0.000658	0.00408	CbGeAlD
Nicardipine—CYP2E1—urethra—urinary bladder cancer	0.000655	0.00407	CbGeAlD
Nicardipine—CYP2C8—female reproductive system—urinary bladder cancer	0.000635	0.00394	CbGeAlD
Nicardipine—CYP2C8—vagina—urinary bladder cancer	0.000574	0.00356	CbGeAlD
Nicardipine—CALM3—lymph node—urinary bladder cancer	0.00057	0.00354	CbGeAlD
Nicardipine—CYP2B6—female reproductive system—urinary bladder cancer	0.000569	0.00354	CbGeAlD
Nicardipine—CYP2C9—female reproductive system—urinary bladder cancer	0.000564	0.0035	CbGeAlD
Nicardipine—ABCB1—prostate gland—urinary bladder cancer	0.000557	0.00346	CbGeAlD
Nicardipine—CYP3A4—renal system—urinary bladder cancer	0.000537	0.00333	CbGeAlD
Nicardipine—CYP2E1—female reproductive system—urinary bladder cancer	0.000534	0.00332	CbGeAlD
Nicardipine—CYP2D6—renal system—urinary bladder cancer	0.000528	0.00328	CbGeAlD
Nicardipine—CYP3A5—vagina—urinary bladder cancer	0.000518	0.00322	CbGeAlD
Nicardipine—CYP2B6—vagina—urinary bladder cancer	0.000515	0.0032	CbGeAlD
Nicardipine—ABCB1—seminal vesicle—urinary bladder cancer	0.000471	0.00293	CbGeAlD
Nicardipine—CALM2—lymph node—urinary bladder cancer	0.000448	0.00278	CbGeAlD
Nicardipine—CALM1—lymph node—urinary bladder cancer	0.000446	0.00277	CbGeAlD
Nicardipine—CYP3A4—female reproductive system—urinary bladder cancer	0.00043	0.00267	CbGeAlD
Nicardipine—CYP2D6—female reproductive system—urinary bladder cancer	0.000423	0.00263	CbGeAlD
Nicardipine—ABCB1—epithelium—urinary bladder cancer	0.00041	0.00254	CbGeAlD
Nicardipine—ABCB1—renal system—urinary bladder cancer	0.00038	0.00236	CbGeAlD
Nicardipine—ABCB1—urethra—urinary bladder cancer	0.000373	0.00232	CbGeAlD
Nicardipine—Oedema—Cisplatin—urinary bladder cancer	0.000335	0.00179	CcSEcCtD
Nicardipine—Infection—Cisplatin—urinary bladder cancer	0.000333	0.00178	CcSEcCtD
Nicardipine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00033	0.00176	CcSEcCtD
Nicardipine—Hypotension—Fluorouracil—urinary bladder cancer	0.00033	0.00176	CcSEcCtD
Nicardipine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000328	0.00175	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000327	0.00175	CcSEcCtD
Nicardipine—Tachycardia—Cisplatin—urinary bladder cancer	0.000327	0.00175	CcSEcCtD
Nicardipine—Insomnia—Gemcitabine—urinary bladder cancer	0.000325	0.00174	CcSEcCtD
Nicardipine—Hypertension—Etoposide—urinary bladder cancer	0.000325	0.00173	CcSEcCtD
Nicardipine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000324	0.00173	CcSEcCtD
Nicardipine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000323	0.00172	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000322	0.00172	CcSEcCtD
Nicardipine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00032	0.00171	CcSEcCtD
Nicardipine—Chest pain—Etoposide—urinary bladder cancer	0.00032	0.00171	CcSEcCtD
Nicardipine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00032	0.00171	CcSEcCtD
Nicardipine—Insomnia—Fluorouracil—urinary bladder cancer	0.00032	0.00171	CcSEcCtD
Nicardipine—Somnolence—Gemcitabine—urinary bladder cancer	0.000319	0.00171	CcSEcCtD
Nicardipine—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000318	0.0017	CcSEcCtD
Nicardipine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000317	0.00169	CcSEcCtD
Nicardipine—Discomfort—Etoposide—urinary bladder cancer	0.000316	0.00169	CcSEcCtD
Nicardipine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000315	0.00168	CcSEcCtD
Nicardipine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000315	0.00168	CcSEcCtD
Nicardipine—Somnolence—Fluorouracil—urinary bladder cancer	0.000314	0.00168	CcSEcCtD
Nicardipine—Hypotension—Cisplatin—urinary bladder cancer	0.000313	0.00167	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—urinary bladder cancer	0.000313	0.00167	CcSEcCtD
Nicardipine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000311	0.00166	CcSEcCtD
Nicardipine—Confusional state—Etoposide—urinary bladder cancer	0.000309	0.00165	CcSEcCtD
Nicardipine—Pain—Gemcitabine—urinary bladder cancer	0.000307	0.00164	CcSEcCtD
Nicardipine—Constipation—Gemcitabine—urinary bladder cancer	0.000307	0.00164	CcSEcCtD
Nicardipine—Asthenia—Thiotepa—urinary bladder cancer	0.000306	0.00164	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000305	0.00163	CcSEcCtD
Nicardipine—Infection—Etoposide—urinary bladder cancer	0.000305	0.00163	CcSEcCtD
Nicardipine—ABCB1—female reproductive system—urinary bladder cancer	0.000304	0.00189	CbGeAlD
Nicardipine—Pain—Fluorouracil—urinary bladder cancer	0.000302	0.00161	CcSEcCtD
Nicardipine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000301	0.00161	CcSEcCtD
Nicardipine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.0003	0.0016	CcSEcCtD
Nicardipine—Tachycardia—Etoposide—urinary bladder cancer	0.000299	0.0016	CcSEcCtD
Nicardipine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000299	0.00159	CcSEcCtD
Nicardipine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000298	0.00159	CcSEcCtD
Nicardipine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000297	0.00158	CcSEcCtD
Nicardipine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000296	0.00158	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000296	0.00158	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000295	0.00157	CcSEcCtD
Nicardipine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000295	0.00157	CcSEcCtD
Nicardipine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000292	0.00156	CcSEcCtD
Nicardipine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000291	0.00155	CcSEcCtD
Nicardipine—Hypotension—Etoposide—urinary bladder cancer	0.000287	0.00153	CcSEcCtD
Nicardipine—Pain—Cisplatin—urinary bladder cancer	0.000286	0.00153	CcSEcCtD
Nicardipine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000284	0.00152	CcSEcCtD
Nicardipine—Dizziness—Thiotepa—urinary bladder cancer	0.000282	0.00151	CcSEcCtD
Nicardipine—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00028	0.0015	CcSEcCtD
Nicardipine—Pollakiuria—Epirubicin—urinary bladder cancer	0.000279	0.00149	CcSEcCtD
Nicardipine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000279	0.00149	CcSEcCtD
Nicardipine—Sweating—Methotrexate—urinary bladder cancer	0.000276	0.00148	CcSEcCtD
Nicardipine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000276	0.00147	CcSEcCtD
Nicardipine—Paraesthesia—Etoposide—urinary bladder cancer	0.000276	0.00147	CcSEcCtD
Nicardipine—ABCB1—vagina—urinary bladder cancer	0.000275	0.00171	CbGeAlD
Nicardipine—Haematuria—Methotrexate—urinary bladder cancer	0.000275	0.00147	CcSEcCtD
Nicardipine—Dyspnoea—Etoposide—urinary bladder cancer	0.000274	0.00146	CcSEcCtD
Nicardipine—Somnolence—Etoposide—urinary bladder cancer	0.000273	0.00146	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000273	0.00146	CcSEcCtD
Nicardipine—Vomiting—Thiotepa—urinary bladder cancer	0.000272	0.00145	CcSEcCtD
Nicardipine—Rash—Thiotepa—urinary bladder cancer	0.000269	0.00144	CcSEcCtD
Nicardipine—Dermatitis—Thiotepa—urinary bladder cancer	0.000269	0.00144	CcSEcCtD
Nicardipine—Headache—Thiotepa—urinary bladder cancer	0.000268	0.00143	CcSEcCtD
Nicardipine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000265	0.00141	CcSEcCtD
Nicardipine—Pain—Etoposide—urinary bladder cancer	0.000262	0.0014	CcSEcCtD
Nicardipine—Constipation—Etoposide—urinary bladder cancer	0.000262	0.0014	CcSEcCtD
Nicardipine—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000262	0.0014	CcSEcCtD
Nicardipine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00026	0.00139	CcSEcCtD
Nicardipine—Sweating—Epirubicin—urinary bladder cancer	0.000259	0.00138	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000259	0.00138	CcSEcCtD
Nicardipine—Asthenia—Gemcitabine—urinary bladder cancer	0.000258	0.00138	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—urinary bladder cancer	0.000257	0.00137	CcSEcCtD
Nicardipine—Nausea—Thiotepa—urinary bladder cancer	0.000254	0.00135	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—urinary bladder cancer	0.000253	0.00135	CcSEcCtD
Nicardipine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000253	0.00135	CcSEcCtD
Nicardipine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000251	0.00134	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—urinary bladder cancer	0.000249	0.00133	CcSEcCtD
Nicardipine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000247	0.00132	CcSEcCtD
Nicardipine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000246	0.00131	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—urinary bladder cancer	0.000243	0.0013	CcSEcCtD
Nicardipine—Body temperature increased—Etoposide—urinary bladder cancer	0.000243	0.0013	CcSEcCtD
Nicardipine—Abdominal pain—Etoposide—urinary bladder cancer	0.000243	0.0013	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000243	0.0013	CcSEcCtD
Nicardipine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000242	0.00129	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—urinary bladder cancer	0.000241	0.00129	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000241	0.00129	CcSEcCtD
Nicardipine—Asthenia—Cisplatin—urinary bladder cancer	0.00024	0.00128	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—urinary bladder cancer	0.000239	0.00128	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000238	0.00127	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—urinary bladder cancer	0.000238	0.00127	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000234	0.00125	CcSEcCtD
Nicardipine—Dizziness—Fluorouracil—urinary bladder cancer	0.000234	0.00125	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—urinary bladder cancer	0.000233	0.00125	CcSEcCtD
Nicardipine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000229	0.00122	CcSEcCtD
Nicardipine—Vomiting—Gemcitabine—urinary bladder cancer	0.000228	0.00122	CcSEcCtD
Nicardipine—Rash—Gemcitabine—urinary bladder cancer	0.000227	0.00121	CcSEcCtD
Nicardipine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000226	0.00121	CcSEcCtD
Nicardipine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000226	0.00121	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—urinary bladder cancer	0.000226	0.00121	CcSEcCtD
Nicardipine—Headache—Gemcitabine—urinary bladder cancer	0.000225	0.0012	CcSEcCtD
Nicardipine—Flushing—Epirubicin—urinary bladder cancer	0.000225	0.0012	CcSEcCtD
Nicardipine—Vomiting—Fluorouracil—urinary bladder cancer	0.000225	0.0012	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000225	0.0012	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000223	0.00119	CcSEcCtD
Nicardipine—Rash—Fluorouracil—urinary bladder cancer	0.000223	0.00119	CcSEcCtD
Nicardipine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000223	0.00119	CcSEcCtD
Nicardipine—Headache—Fluorouracil—urinary bladder cancer	0.000221	0.00118	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000221	0.00118	CcSEcCtD
Nicardipine—Asthenia—Etoposide—urinary bladder cancer	0.00022	0.00118	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000216	0.00115	CcSEcCtD
Nicardipine—Nausea—Gemcitabine—urinary bladder cancer	0.000213	0.00114	CcSEcCtD
Nicardipine—Vomiting—Cisplatin—urinary bladder cancer	0.000213	0.00114	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—urinary bladder cancer	0.000212	0.00113	CcSEcCtD
Nicardipine—Rash—Cisplatin—urinary bladder cancer	0.000211	0.00113	CcSEcCtD
Nicardipine—Dermatitis—Cisplatin—urinary bladder cancer	0.000211	0.00113	CcSEcCtD
Nicardipine—Diarrhoea—Etoposide—urinary bladder cancer	0.00021	0.00112	CcSEcCtD
Nicardipine—Nausea—Fluorouracil—urinary bladder cancer	0.00021	0.00112	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000209	0.00112	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000209	0.00112	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—urinary bladder cancer	0.000208	0.00111	CcSEcCtD
Nicardipine—Tension—Epirubicin—urinary bladder cancer	0.000207	0.0011	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—urinary bladder cancer	0.000205	0.00109	CcSEcCtD
Nicardipine—Malaise—Methotrexate—urinary bladder cancer	0.000203	0.00108	CcSEcCtD
Nicardipine—Dizziness—Etoposide—urinary bladder cancer	0.000203	0.00108	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—urinary bladder cancer	0.000202	0.00108	CcSEcCtD
Nicardipine—Nausea—Cisplatin—urinary bladder cancer	0.000199	0.00106	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—urinary bladder cancer	0.000199	0.00106	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000196	0.00104	CcSEcCtD
Nicardipine—Vomiting—Etoposide—urinary bladder cancer	0.000195	0.00104	CcSEcCtD
Nicardipine—Agitation—Epirubicin—urinary bladder cancer	0.000194	0.00103	CcSEcCtD
Nicardipine—Rash—Etoposide—urinary bladder cancer	0.000193	0.00103	CcSEcCtD
Nicardipine—Dermatitis—Etoposide—urinary bladder cancer	0.000193	0.00103	CcSEcCtD
Nicardipine—Headache—Etoposide—urinary bladder cancer	0.000192	0.00103	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—urinary bladder cancer	0.000192	0.00102	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—urinary bladder cancer	0.000192	0.00102	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—urinary bladder cancer	0.000192	0.00102	CcSEcCtD
Nicardipine—Tension—Doxorubicin—urinary bladder cancer	0.000191	0.00102	CcSEcCtD
Nicardipine—Malaise—Epirubicin—urinary bladder cancer	0.00019	0.00101	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—urinary bladder cancer	0.000189	0.00101	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—urinary bladder cancer	0.000189	0.00101	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—urinary bladder cancer	0.000189	0.00101	CcSEcCtD
Nicardipine—Syncope—Epirubicin—urinary bladder cancer	0.000189	0.00101	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—urinary bladder cancer	0.000186	0.000994	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—urinary bladder cancer	0.000185	0.000989	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000185	0.000989	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000184	0.000981	CcSEcCtD
Nicardipine—Infection—Methotrexate—urinary bladder cancer	0.000183	0.000975	CcSEcCtD
Nicardipine—Nausea—Etoposide—urinary bladder cancer	0.000182	0.000973	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—urinary bladder cancer	0.000182	0.000971	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000181	0.000966	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00018	0.000961	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—urinary bladder cancer	0.000179	0.000958	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—urinary bladder cancer	0.000179	0.000958	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—urinary bladder cancer	0.000179	0.000958	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—urinary bladder cancer	0.000179	0.000957	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—urinary bladder cancer	0.000179	0.000955	CcSEcCtD
Nicardipine—ABCB1—lymph node—urinary bladder cancer	0.000178	0.00111	CbGeAlD
Nicardipine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000178	0.000949	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—urinary bladder cancer	0.000177	0.000946	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—urinary bladder cancer	0.000176	0.000939	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—urinary bladder cancer	0.000175	0.000937	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—urinary bladder cancer	0.000175	0.000935	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—urinary bladder cancer	0.000175	0.000934	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—urinary bladder cancer	0.000173	0.000926	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—urinary bladder cancer	0.000172	0.00092	CcSEcCtD
Nicardipine—Oedema—Epirubicin—urinary bladder cancer	0.000172	0.000918	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—urinary bladder cancer	0.000172	0.000917	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000171	0.000915	CcSEcCtD
Nicardipine—Infection—Epirubicin—urinary bladder cancer	0.000171	0.000912	CcSEcCtD
Nicardipine—Shock—Epirubicin—urinary bladder cancer	0.000169	0.000903	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000168	0.000899	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—urinary bladder cancer	0.000168	0.000899	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—urinary bladder cancer	0.000168	0.000896	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000167	0.000894	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000166	0.000888	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—urinary bladder cancer	0.000166	0.000888	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—urinary bladder cancer	0.000166	0.000886	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000166	0.000886	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—urinary bladder cancer	0.000166	0.000886	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—urinary bladder cancer	0.000165	0.000883	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000165	0.000881	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—urinary bladder cancer	0.000164	0.000876	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000164	0.000875	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—urinary bladder cancer	0.000163	0.000872	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000162	0.000867	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000162	0.000864	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—urinary bladder cancer	0.000161	0.000858	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—urinary bladder cancer	0.00016	0.000857	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—urinary bladder cancer	0.000159	0.00085	CcSEcCtD
Nicardipine—Infection—Doxorubicin—urinary bladder cancer	0.000158	0.000844	CcSEcCtD
Nicardipine—Pain—Methotrexate—urinary bladder cancer	0.000157	0.000839	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000157	0.000837	CcSEcCtD
Nicardipine—Shock—Doxorubicin—urinary bladder cancer	0.000157	0.000836	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000156	0.000832	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—urinary bladder cancer	0.000156	0.000831	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000155	0.000829	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000154	0.000825	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000154	0.000821	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000153	0.000819	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—urinary bladder cancer	0.000153	0.000816	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000151	0.000809	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000151	0.000808	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00015	0.000802	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—urinary bladder cancer	0.000149	0.000794	CcSEcCtD
Nicardipine—Pain—Epirubicin—urinary bladder cancer	0.000147	0.000785	CcSEcCtD
Nicardipine—Constipation—Epirubicin—urinary bladder cancer	0.000147	0.000785	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000145	0.000776	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000145	0.000776	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000145	0.000774	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—urinary bladder cancer	0.000144	0.000769	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000143	0.000763	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000142	0.000758	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000142	0.000757	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—urinary bladder cancer	0.000141	0.000755	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000141	0.000751	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00014	0.000748	CcSEcCtD
Nicardipine—Pain—Doxorubicin—urinary bladder cancer	0.000136	0.000727	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—urinary bladder cancer	0.000136	0.000727	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000136	0.000726	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000136	0.000726	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000135	0.000723	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—urinary bladder cancer	0.000132	0.000704	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000131	0.0007	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00013	0.000695	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000127	0.000677	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000126	0.000672	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000126	0.000672	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000126	0.000671	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—urinary bladder cancer	0.000123	0.000659	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—urinary bladder cancer	0.000122	0.000649	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000118	0.000628	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000117	0.000626	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—urinary bladder cancer	0.000117	0.000624	CcSEcCtD
Nicardipine—Rash—Methotrexate—urinary bladder cancer	0.000116	0.000619	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—urinary bladder cancer	0.000116	0.000618	CcSEcCtD
Nicardipine—Headache—Methotrexate—urinary bladder cancer	0.000115	0.000615	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—urinary bladder cancer	0.000114	0.00061	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—urinary bladder cancer	0.000114	0.000607	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—urinary bladder cancer	0.000109	0.000584	CcSEcCtD
Nicardipine—Nausea—Methotrexate—urinary bladder cancer	0.000109	0.000583	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000109	0.000581	CcSEcCtD
Nicardipine—Rash—Epirubicin—urinary bladder cancer	0.000108	0.000579	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—urinary bladder cancer	0.000108	0.000578	CcSEcCtD
Nicardipine—Headache—Epirubicin—urinary bladder cancer	0.000108	0.000575	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—urinary bladder cancer	0.000105	0.000562	CcSEcCtD
Nicardipine—Nausea—Epirubicin—urinary bladder cancer	0.000102	0.000545	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—urinary bladder cancer	0.000101	0.00054	CcSEcCtD
Nicardipine—Rash—Doxorubicin—urinary bladder cancer	0.0001	0.000536	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—urinary bladder cancer	0.0001	0.000535	CcSEcCtD
Nicardipine—Headache—Doxorubicin—urinary bladder cancer	9.97e-05	0.000532	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—urinary bladder cancer	9.45e-05	0.000505	CcSEcCtD
Nicardipine—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	7.16e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PTEN—urinary bladder cancer	7.15e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PTEN—urinary bladder cancer	7.15e-06	4.27e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	7.14e-06	4.26e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—SRC—urinary bladder cancer	7.09e-06	4.23e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.08e-06	4.23e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CXCL8—urinary bladder cancer	7.05e-06	4.21e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MYC—urinary bladder cancer	7.05e-06	4.21e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EP300—urinary bladder cancer	7.05e-06	4.21e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—HRAS—urinary bladder cancer	7.01e-06	4.18e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	6.96e-06	4.15e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EGFR—urinary bladder cancer	6.9e-06	4.12e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—SRC—urinary bladder cancer	6.85e-06	4.09e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—CDKN1A—urinary bladder cancer	6.84e-06	4.08e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PTEN—urinary bladder cancer	6.82e-06	4.07e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTEN—urinary bladder cancer	6.82e-06	4.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EP300—urinary bladder cancer	6.82e-06	4.07e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EP300—urinary bladder cancer	6.82e-06	4.07e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MYC—urinary bladder cancer	6.76e-06	4.03e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL2—urinary bladder cancer	6.74e-06	4.02e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	6.73e-06	4.02e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	6.71e-06	4.01e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—ERBB2—urinary bladder cancer	6.69e-06	3.99e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CREBBP—urinary bladder cancer	6.69e-06	3.99e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—SRC—urinary bladder cancer	6.63e-06	3.96e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—SRC—urinary bladder cancer	6.63e-06	3.96e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	6.63e-06	3.96e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—CDKN1A—urinary bladder cancer	6.61e-06	3.95e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—CDKN1A—urinary bladder cancer	6.61e-06	3.95e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	6.61e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EGFR—urinary bladder cancer	6.61e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IGF1—urinary bladder cancer	6.61e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTEN—urinary bladder cancer	6.6e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTEN—urinary bladder cancer	6.6e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	6.59e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	6.58e-06	3.93e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EGFR—urinary bladder cancer	6.57e-06	3.92e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCND1—urinary bladder cancer	6.57e-06	3.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—urinary bladder cancer	6.55e-06	3.91e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—KRAS—urinary bladder cancer	6.52e-06	3.89e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—EP300—urinary bladder cancer	6.51e-06	3.88e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EP300—urinary bladder cancer	6.51e-06	3.88e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CREBBP—urinary bladder cancer	6.47e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CREBBP—urinary bladder cancer	6.47e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	6.47e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IGF1—urinary bladder cancer	6.39e-06	3.81e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IGF1—urinary bladder cancer	6.39e-06	3.81e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MMP9—urinary bladder cancer	6.38e-06	3.81e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	6.37e-06	3.8e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—urinary bladder cancer	6.36e-06	3.8e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—urinary bladder cancer	6.36e-06	3.8e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CDKN1A—urinary bladder cancer	6.36e-06	3.8e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MYC—urinary bladder cancer	6.35e-06	3.79e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CXCL8—urinary bladder cancer	6.35e-06	3.79e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PTEN—urinary bladder cancer	6.34e-06	3.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—urinary bladder cancer	6.34e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—urinary bladder cancer	6.34e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—SRC—urinary bladder cancer	6.33e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	6.32e-06	3.78e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PPARG—urinary bladder cancer	6.31e-06	3.77e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—HRAS—urinary bladder cancer	6.3e-06	3.76e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EP300—urinary bladder cancer	6.29e-06	3.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EP300—urinary bladder cancer	6.29e-06	3.76e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	6.28e-06	3.75e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	6.27e-06	3.74e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	6.24e-06	3.73e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—KRAS—urinary bladder cancer	6.24e-06	3.73e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	6.23e-06	3.72e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—urinary bladder cancer	6.21e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	6.21e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—KRAS—urinary bladder cancer	6.21e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—SRC—urinary bladder cancer	6.12e-06	3.65e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—SRC—urinary bladder cancer	6.12e-06	3.65e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	6.08e-06	3.63e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	6.06e-06	3.62e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.06e-06	3.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—RHOA—urinary bladder cancer	6.05e-06	3.61e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	6.05e-06	3.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—KRAS—urinary bladder cancer	6.01e-06	3.59e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—KRAS—urinary bladder cancer	6.01e-06	3.59e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—urinary bladder cancer	6.01e-06	3.59e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	6.01e-06	3.58e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	5.99e-06	3.57e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	5.95e-06	3.55e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	5.93e-06	3.54e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	5.91e-06	3.53e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.9e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	5.9e-06	3.52e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	5.88e-06	3.51e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	5.87e-06	3.5e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KRAS—urinary bladder cancer	5.87e-06	3.5e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	5.85e-06	3.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—RHOA—urinary bladder cancer	5.85e-06	3.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—RHOA—urinary bladder cancer	5.85e-06	3.49e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	5.84e-06	3.48e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—urinary bladder cancer	5.81e-06	3.47e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—urinary bladder cancer	5.81e-06	3.47e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—urinary bladder cancer	5.79e-06	3.46e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	5.76e-06	3.44e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	5.75e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	5.74e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	5.74e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.74e-06	3.42e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	5.72e-06	3.42e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	5.72e-06	3.41e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	5.71e-06	3.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTEN—urinary bladder cancer	5.71e-06	3.41e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	5.71e-06	3.41e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	5.7e-06	3.4e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	5.68e-06	3.39e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KRAS—urinary bladder cancer	5.67e-06	3.39e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—urinary bladder cancer	5.67e-06	3.38e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	5.67e-06	3.38e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	5.66e-06	3.38e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	5.66e-06	3.38e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	5.65e-06	3.37e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	5.65e-06	3.37e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	5.63e-06	3.36e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ERBB2—urinary bladder cancer	5.6e-06	3.34e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—EP300—urinary bladder cancer	5.6e-06	3.34e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—urinary bladder cancer	5.55e-06	3.31e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—urinary bladder cancer	5.54e-06	3.31e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—urinary bladder cancer	5.54e-06	3.31e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTEN—urinary bladder cancer	5.53e-06	3.3e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTEN—urinary bladder cancer	5.53e-06	3.3e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.49e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—urinary bladder cancer	5.49e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—urinary bladder cancer	5.49e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—urinary bladder cancer	5.48e-06	3.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—urinary bladder cancer	5.48e-06	3.27e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—EP300—urinary bladder cancer	5.48e-06	3.27e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—EP300—urinary bladder cancer	5.47e-06	3.27e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	5.46e-06	3.26e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—EP300—urinary bladder cancer	5.45e-06	3.25e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	5.44e-06	3.25e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.43e-06	3.24e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.43e-06	3.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—urinary bladder cancer	5.42e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—urinary bladder cancer	5.42e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	5.39e-06	3.22e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	5.37e-06	3.21e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—urinary bladder cancer	5.36e-06	3.2e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—urinary bladder cancer	5.36e-06	3.2e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—urinary bladder cancer	5.31e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	5.31e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—urinary bladder cancer	5.31e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	5.29e-06	3.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—urinary bladder cancer	5.28e-06	3.15e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	5.27e-06	3.15e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—EP300—urinary bladder cancer	5.27e-06	3.15e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—EP300—urinary bladder cancer	5.27e-06	3.15e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	5.24e-06	3.13e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—urinary bladder cancer	5.24e-06	3.13e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	5.23e-06	3.12e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—urinary bladder cancer	5.22e-06	3.11e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.2e-06	3.1e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	5.16e-06	3.08e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—urinary bladder cancer	5.14e-06	3.07e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—urinary bladder cancer	5.14e-06	3.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—urinary bladder cancer	5.11e-06	3.05e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—urinary bladder cancer	5.11e-06	3.05e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.1e-06	3.05e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	5.09e-06	3.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—urinary bladder cancer	5.08e-06	3.03e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—urinary bladder cancer	5.07e-06	3.02e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—urinary bladder cancer	5.07e-06	3.02e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—urinary bladder cancer	4.99e-06	2.98e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	4.97e-06	2.97e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.96e-06	2.96e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—urinary bladder cancer	4.95e-06	2.95e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—urinary bladder cancer	4.91e-06	2.93e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—urinary bladder cancer	4.91e-06	2.93e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	4.87e-06	2.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—urinary bladder cancer	4.82e-06	2.88e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—urinary bladder cancer	4.81e-06	2.87e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.79e-06	2.86e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1A—urinary bladder cancer	4.79e-06	2.86e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—urinary bladder cancer	4.79e-06	2.86e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—urinary bladder cancer	4.79e-06	2.86e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—urinary bladder cancer	4.78e-06	2.85e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	4.76e-06	2.84e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	4.74e-06	2.83e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—EP300—urinary bladder cancer	4.74e-06	2.83e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	4.7e-06	2.8e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	4.68e-06	2.8e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.68e-06	2.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—urinary bladder cancer	4.66e-06	2.78e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—urinary bladder cancer	4.66e-06	2.78e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	4.65e-06	2.78e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—urinary bladder cancer	4.65e-06	2.77e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—urinary bladder cancer	4.65e-06	2.77e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	4.64e-06	2.77e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	4.64e-06	2.77e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1A—urinary bladder cancer	4.63e-06	2.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1A—urinary bladder cancer	4.63e-06	2.76e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—urinary bladder cancer	4.62e-06	2.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—urinary bladder cancer	4.62e-06	2.76e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	4.59e-06	2.74e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	4.58e-06	2.73e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EP300—urinary bladder cancer	4.56e-06	2.72e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—urinary bladder cancer	4.45e-06	2.66e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	4.44e-06	2.65e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SRC—urinary bladder cancer	4.43e-06	2.64e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EP300—urinary bladder cancer	4.41e-06	2.63e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EP300—urinary bladder cancer	4.41e-06	2.63e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	4.4e-06	2.62e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	4.38e-06	2.62e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	4.34e-06	2.59e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.33e-06	2.58e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	4.33e-06	2.58e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	4.33e-06	2.58e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—urinary bladder cancer	4.31e-06	2.57e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—urinary bladder cancer	4.31e-06	2.57e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SRC—urinary bladder cancer	4.29e-06	2.56e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SRC—urinary bladder cancer	4.29e-06	2.56e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.23e-06	2.53e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	4.14e-06	2.47e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.13e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.08e-06	2.44e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	4.04e-06	2.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—urinary bladder cancer	3.97e-06	2.37e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	3.91e-06	2.33e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	3.89e-06	2.32e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.89e-06	2.32e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.89e-06	2.32e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—urinary bladder cancer	3.88e-06	2.32e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.86e-06	2.3e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	3.86e-06	2.3e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	3.85e-06	2.3e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—urinary bladder cancer	3.84e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—urinary bladder cancer	3.84e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—urinary bladder cancer	3.76e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—urinary bladder cancer	3.76e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	3.74e-06	2.23e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.74e-06	2.23e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	3.72e-06	2.22e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	3.69e-06	2.2e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	3.68e-06	2.2e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—urinary bladder cancer	3.67e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—urinary bladder cancer	3.55e-06	2.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—urinary bladder cancer	3.55e-06	2.12e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—urinary bladder cancer	3.26e-06	1.95e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—urinary bladder cancer	3.15e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—urinary bladder cancer	3.15e-06	1.88e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—urinary bladder cancer	3.12e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.06e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—urinary bladder cancer	3.02e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—urinary bladder cancer	3.02e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.67e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.54e-06	1.52e-05	CbGpPWpGaD
